Current status of the development of dengue vaccines
Authors:
Open Access
- 18 December 2024
- journal article
- research article
- Published by Elsevier in Vaccine: X
- Vol. 22, 100604
Abstract
No abstract availableKeywords
This publication has 134 references indexed in Scilit:
- Antibody-Dependent Enhancement (ADE) and the role of complement system in disease pathogenesisMolecular Immunology, 2022
- Design of an Epitope-Based Peptide Vaccine Against Dengue Virus Isolate from Eastern Uttar Pradesh, IndiaInternational Journal of Peptide Research and Therapeutics, 2022
- Co-circulation of three dengue virus serotypes led to a severe dengue outbreak in Xishuangbanna, a border area of China, Myanmar, and Laos, in 2019International Journal of Infectious Diseases, 2021
- Modified mRNA-LNP Vaccines Confer Protection against Experimental DENV-2 Infection in MiceMolecular Therapy - Methods & Clinical Development, 2020
- Dengue: Status of current and under‐development vaccinesReviews in Medical Virology, 2020
- Prevalence and burden of dengue infection in Europe: A systematic review and meta‐analysisReviews in Medical Virology, 2019
- Dengue virus NS2 and NS4: Minor proteins, mammoth rolesBiochemical Pharmacology, 2018
- Production and Purification of Recombinant Proteins from Escherichia coliChemBioEng Reviews, 2016
- Viremia and Immunogenicity in Nonhuman Primates of a Tetravalent Yellow Fever–Dengue Chimeric Vaccine: Genetic Reconstructions, Dose Adjustment, and Antibody Responses against Wild-type Dengue Virus IsolatesVirology, 2002
- Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteersVaccine, 1996